OTC Healthcare - Poland
OTC Healthcare in Poland : Market Insight
EXECUTIVE SUMMARY
The growth slows down Multinationals lead Producers seek new value added opportunities Advertising is a key Banned Internet sales Good prospects for core OTC categories KEY TRENDS AND DEVELOPMENTS
Ageing population means more opportunities Ambitious domestic companies despite strong pressure of multinationals Civilization diseases affect consumers'' decisions MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - Poland
Aflofarm Farmacja Polska sp z oo - OTC Healthcare - Poland
STRATEGIC DIRECTION KEY FACTS
Summary 2 Aflofarm Farmacja Polska sp z oo: Key Facts
Summary 3 Aflofarm Farmacja Polska sp z oo: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Aflofarm Farmacja Polska sp z oo: Competitive Position 2006
Grupa Maspex Wadowice - OTC Healthcare - Poland
STRATEGIC DIRECTION KEY FACTS
Summary 5 Maspex Sp zoo: Key Facts
Summary 6 Maspex Sp zoo: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 7 Maspex Sp zoo: Competitive Position 2006
Herbapol Wroclaw SA - OTC Healthcare - Poland
STRATEGIC DIRECTION KEY FACTS
Summary 8 Herbapol Wroclaw SA Key Facts
Summary 9 Herbapol Wroclaw SA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 10 Herbapol Wroclaw SA: Competitive Position 2006
Jelfa SA - OTC Healthcare - Poland
STRATEGIC DIRECTION KEY FACTS
Summary 11 Jelfa SA: Key Facts
Summary 12 Jelfa SA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 13 Jelfa SA: Competitive Position 2006
Polpharma SA - OTC Healthcare - Poland
STRATEGIC DIRECTION KEY FACTS
Summary 14 Polpharma SA: Key Facts
Summary 15 Polpharma SA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 16 Polpharma SA: Competitive Position 2006
NRT Smoking cessation aids in Poland
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 11 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 12 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 13 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 14 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 15 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
